| PUBLICATIONS (Ranked by impact factor of the journal) | LABORATORY RESEARCH GRP78 Regulates Clusterin Stability, Retrotranslocation and Mitochondrial Localization Under ER Stress in Prostate Cancer Using human prostate cancer cells, researchers showed that GRP78 associates with clusterin under endoplasmic reticulum (ER) stress conditions to facilitate its retrotranslocation and redistribution to the mitochondria. [Oncogene] Abstract Poly[3-(3, 4-Dihydroxyphenyl) Glyceric] Acid from Comfrey Exerts Anti-Cancer Efficacy Against Human Prostate Cancer via Targeting Androgen Receptor, Cell Cycle Arrest and Apoptosis Researchers investigated the efficacy of a novel phytochemical poly[3-(3, 4-dihydroxyphenyl)glyceric acid] from Caucasian species of comfrey (Symphytum caucasicum) and its synthetic derivative syn-2, 3-dihydroxy-3-(3, 4-dihydroxyphenyl) propionic acid against human prostate cancer LNCaP and 22Rv1 cells. [Carcinogenesis] Abstract Co-Targeting Stress-Activated Hsp27 and Autophagy as a Combinatorial Strategy to Amplify Endoplasmic Reticular Stress in Prostate Cancer Investigators reported that heat shock protein-27 (Hsp27) protects human prostate cancer cells against proteotoxic stress induced by proteasome inhibition, and that Hsp27 silencing using siRNA or antisense induced both apoptosis and autophagy through mechanisms involving reduced proteasome activity and induction of endoplasmic reticulum stress. [Mol Cancer Ther] Abstract A Selective Inhibitor of the Immunoproteasome Subunit LMP2 Induces Apoptosis in PC-3 Cells and Suppresses Tumor Growth in Nude Mice To validate the immunoproteasome as a chemotherapeutic target, an immunoproteasome catalytic subunit LMP2-targeting inhibitor and siRNA were used. The sensitivity of PC-3 prostate cancer cells to these reagents was investigated using viability assays. [Br J Cancer] Abstract Flavonoid Ampelopsin Inhibits the Growth and Metastasis of Prostate Cancer In Vitro and in Mice Scientists evaluated the chemopreventive effect of a novel flavonoid, ampelopsin on the growth and metastasis of prostate cancer cells. [PLoS One] Full Article Differential Tumorigenic Potential and Matriptase Activation between PDGF B vs. PDGF D in Prostate Cancer Investigators examined potential oncogenic functions of ß-platelet-derived growth factor (ß-PDGFR) ligands PDGF B and PDGF D, utilizing non-malignant prostate epithelial cells engineered to overexpress these ligands. [Mol Cancer Res] Abstract Expression of TGFß3 and Its Effects on Migratory and Invasive Behavior of Prostate Cancer Cells: Involvement of PI3-kinase/AKT Signaling Pathway Researchers carried out expression analysis of transforming growth factor-ß (TGFß) isoforms and signaling components in cell line models representing different stages of prostate cancer and studied the differential effects of specific isoforms on migratory and invasive behavior and induction of the PI3-kinase pathway. [Clin Exp Metastasis] Abstract Androgen-Independent Prostate Cancer Cells Circumvent EGFR Inhibition by Overexpression of Alternative HER Receptors and Ligands A potential mechanism to overcome epidermal growth factor receptor (EGFR) blockade in cancer cells is the autocrine activation of alternative receptors of the human EGFR (HER) family through the overexpression of the HER receptors and ligands. Here, researchers analyzed if this intrinsic resistance mechanism might contribute to the inefficacy of EGFR inhibitors in prostate cancer. [Int J Oncol] Abstract CLINICAL RESEARCH Randomized Phase II/III Study of Docetaxel with or without Risedronate in Patients with Metastatic Castration Resistant Prostate Cancer, the Netherlands Prostate Study Researchers aimed to investigate the potential benefit of adding risedronate to docetaxel in patients with metastatic castration resistant prostate cancer. [Eur J Cancer] Abstract Hypofractionated High-Dose Radiation Therapy for Prostate Cancer: Long-Term Results of a Multi-Institutional Phase II Trial Scientists reported late gastrointestinal and genitourinary toxicity, biochemical and clinical outcomes, and overall survival after hypofractionated radiation therapy for prostate cancer. [Int J Radiat Oncol Biol Phys] Abstract PCA3 Sensitivity and Specificity for Prostate Cancer Detection in Patients with Abnormal Prostate Specific Antigen and/or Suspicious Digital Rectal Examination. First Latin American Experience Researchers described the application of the PROGENSA PCA3 assay for prostate cancer gene 3 (PCA3) detection in urine in Chilean men and its utility for prostate cancer diagnosis in men with an indication of prostate biopsy. [Urol Oncol] Abstract |
| JOB OPPORTUNITIES | Research Associate – Chemistry (STEMCELL Technologies, Inc.) Research Associate – Particle Chemistry (STEMCELL Technologies, Inc.) Research Technologist – Contract Assay Services (STEMCELL Technologies, Inc.) Research Technologist – Media Development (STEMCELL Technologies, Inc.) Scientist – Epithelial Cell Research (STEMCELL Technologies, Inc.) Scientist – Induced Pluripotent Stem Cells (STEMCELL Technologies, Inc.) Scientist – Mesenchymal Cell Research (STEMCELL Technologies, Inc.) Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.) Associate Research Scientist – Stem Cells and Prostate Epithelium (Columbia University Medical Center) Clinical Research Associate – Cancer (Jennerex Biotherapeutics, Inc.) Postdoctoral Position – Cancer Genomics (University of California) Research Associate – Development (Precision Therapeutics, Inc.) Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost. |
|
|
|